RetroSense Therapeutics Completes pre-IND Meeting for RST-001RetroSense Therapeutics, a gene therapy company dedicated to vision restoration, announced completion of a pre-IND meeting with the Center for Biological Evaluation and Research division of the FDA that took place on May 22 regarding RetroSense’s lead product candidate, RST-001 for vision restoration in retinal degenerative conditions.
Perrigo Files For Generic Astepro Nasal Spray, Patent LawsuitPerrigo Co. (Nasdaq: PRGO) announced that it has filed with the United States Food and Drug Administration an Abbreviated New Drug Application for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals Inc., the owner of the New Drug Application of its filing.
Food Protection Institute Gets FDA GrantThe International Food Protection Training Institute, a non-profit organization delivering career-spanning, standards-based training to food safety officials, announced it had received a multi-year grant of $1.3 million per year from the United States Food and Drug Administration.
Perrigo Announces FDA Approval For Generic Equivalent to ZantacAllegan-based Perrigo Co. (Nasdaq: PRGO) announced that it has received final approval from the United States Food and Drug Administration for its abbreviated new drug application for over-the-counter Ranitidine 150 (regular and cool mint), a generic version of Zantac 150.
FDA Clears Perrigo Allegan Manufacturing Plant In Re-InspectionAllegan-based Perrigo Co. announced that it had achieved "acceptable regulatory status" in a re-inspection of its Allegal manufacturing plant by the Detroit office of the United States Food and Drug Administration.
Stem Cell Summit: Cure For Paralysis And More?
Royal Oak Firm Gets FDA Clearance For Surgical Product